Contact UsCompany ProfileHome
Saaskin Technologies
Send Inquiry Send SMS    Call Me Free
ZYBIO EXI BNP (CLIA) ZYBIO EXI BNP (CLIA)
ZYBIO EXI BNP (CLIA)
ZYBIO EXI BNP (CLIA)

ZYBIO EXI BNP (CLIA)

Product Details:

  • Usage Type Laboratory
  • Storage Instructions 2 to 8 Degree Celsius
  • Equipment Type CLIA Analyzer
  • Condition New
  • Technology Chemiluminescence Immunoassay (CLIA)
  • Portable Yes
  • Wall Mounted No
  • Click to View more
X

ZYBIO EXI BNP (CLIA) Price And Quantity

  • 1 Unit

ZYBIO EXI BNP (CLIA) Product Specifications

  • Yes
  • 2 to 8 Degree Celsius
  • No
  • Automatic
  • Yes
  • New
  • Chemiluminescence Immunoassay (CLIA)
  • Laboratory
  • CLIA Analyzer
  • Determination of B-Type Natriuretic Peptide (BNP)

Product Description

Brand Zybio
Sample Type Plasma
Pack Size 2 x 50T
CAT No 0604201
Application
Cardiac Marker
ZYBIO CLIA B-Type Natriuretic Peptide(BNP) reagent kit is designed for accurate quantitative determination of B-Type Natriuretic Peptide (BNP) levels using chemiluminescent immunoassay technology. This Cardiac Biomarker test reagent is intended to aid in the diagnosis, risk assessment, and monitoring of heart failure(HF).

Advanced Chemiluminescence Technology

The ZYBIO EXI BNP utilizes chemiluminescence immunoassay (CLIA) technology, ensuring high sensitivity and specificity in BNP measurement. This innovation improves result accuracy and speeds up diagnostic processes in the laboratory.


Automatic Operation for Enhanced Workflow

With automatic operating capabilities, this CLIA Analyzer significantly reduces manual intervention. Laboratory staff benefit from streamlined testing procedures, resulting in more consistent output and reduced chances of human error.


Portability and Storage Efficiency

Designed to be portable and easy to integrate into various laboratory settings, the ZYBIO EXI BNP takes up minimal space. Proper storage between 2 to 8C maintains the device's performance, ensuring reliable results over its lifetime.

FAQ's of ZYBIO EXI BNP (CLIA):


Q: How does the ZYBIO EXI BNP (CLIA) analyzer work in the laboratory?

A: The ZYBIO EXI BNP uses chemiluminescence immunoassay (CLIA) technology to automatically detect and measure B-Type Natriuretic Peptide (BNP) levels in patient samples. Its automated operation streamlines the process, requiring minimal manual handling and providing accurate results rapidly.

Q: What is the primary use of the ZYBIO EXI BNP (CLIA) analyzer?

A: This analyzer is primarily used for the quantitative determination of B-Type Natriuretic Peptide (BNP) in laboratories. BNP measurement supports the diagnosis and monitoring of heart-related conditions, particularly heart failure.

Q: When should the ZYBIO EXI BNP (CLIA) be used in clinical settings?

A: It should be used whenever precise and timely measurement of BNP is required, especially in the evaluation, diagnosis, or monitoring of patients suspected of having heart failure or other cardiac dysfunctions.

Q: Where can I purchase or source the ZYBIO EXI BNP (CLIA) analyzer in India?

A: The ZYBIO EXI BNP (CLIA) is available through authorized dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers across India.

Q: What is the recommended storage condition for the ZYBIO EXI BNP (CLIA) analyzer?

A: To ensure optimal performance and longevity, store the analyzer at temperatures between 2 to 8 degrees Celsius, away from direct sunlight and moisture.

Q: What are the benefits of using the ZYBIO EXI BNP (CLIA) analyzer?

A: Key benefits include high sensitivity due to CLIA technology, automation for reduced labor, portable design for flexible placement, reliable real-time operation, and improved diagnostic accuracy for cardiac conditions.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Medical CLIA' category



trade india member
SAASKIN CORPORATION PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.